Keppra And Velcade Rivals Among Sawai’s New Listings
Japanese Firm Unveils Raft Of Five New Products In Nine Presentations
Rivals to Careram, Keppra, Patanol, Velcade and Volibris have been listed with Japan’s NHI drug price list by Sawai, as the company seeks to capitalize on its position as a leading supplier in the market.
